MARCHETTI, Bianca Maria
 Distribuzione geografica
Continente #
NA - Nord America 5.066
EU - Europa 2.038
AS - Asia 1.530
SA - Sud America 229
AF - Africa 117
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 8.991
Nazione #
US - Stati Uniti d'America 4.846
SG - Singapore 857
IE - Irlanda 609
UA - Ucraina 599
CN - Cina 575
IT - Italia 402
BR - Brasile 219
CA - Canada 210
RU - Federazione Russa 150
SE - Svezia 95
SN - Senegal 62
DE - Germania 55
CI - Costa d'Avorio 47
IN - India 28
GB - Regno Unito 26
CH - Svizzera 19
FR - Francia 17
GR - Grecia 12
IR - Iran 12
PL - Polonia 12
AT - Austria 11
NL - Olanda 11
IQ - Iraq 8
UZ - Uzbekistan 7
EU - Europa 6
LB - Libano 6
VN - Vietnam 6
BE - Belgio 5
JP - Giappone 5
NG - Nigeria 5
BD - Bangladesh 4
CZ - Repubblica Ceca 4
AR - Argentina 3
AU - Australia 3
FI - Finlandia 3
HK - Hong Kong 3
MX - Messico 3
NP - Nepal 3
TR - Turchia 3
BH - Bahrain 2
CO - Colombia 2
EC - Ecuador 2
HN - Honduras 2
ID - Indonesia 2
IL - Israele 2
NZ - Nuova Zelanda 2
PA - Panama 2
TH - Thailandia 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
DO - Repubblica Dominicana 1
ES - Italia 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
MA - Marocco 1
ME - Montenegro 1
MK - Macedonia 1
NI - Nicaragua 1
OM - Oman 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 8.991
Città #
Santa Clara 832
Jacksonville 736
Dublin 608
Chandler 551
Singapore 482
Houston 406
Boardman 271
Nanjing 173
Lawrence 172
Cambridge 171
Andover 168
Toronto 162
Chicago 161
Catania 118
Des Moines 108
San Mateo 90
Wilmington 82
Ashburn 67
Nanchang 63
Dakar 62
Shenyang 53
Abidjan 47
Ottawa 47
Civitanova Marche 46
Hebei 45
Council Bluffs 34
Falls Church 33
Saint Petersburg 32
Tianjin 31
Changsha 28
Jiaxing 27
The Dalles 27
Moscow 20
Rome 18
Seattle 17
Grafing 16
Jinan 16
Los Angeles 16
Beijing 15
Aversa 14
Norwalk 14
Leawood 13
Augusta 12
Pune 12
Tappahannock 12
Ardabil 11
Belo Horizonte 11
Kunming 10
Liberty Lake 10
Mascalucia 9
Ragusa 9
São Paulo 9
Washington 9
Ann Arbor 8
Frankfurt Am Main 8
Hangzhou 8
Bremen 6
San Francisco 6
Taormina 6
Brussels 5
Fuzhou 5
Goiânia 5
Milan 5
Munich 5
Redwood City 5
Serramanna 5
Trecastagni 5
Volta Redonda 5
Abuja 4
Aci Catena 4
Baghdad 4
Bari 4
Changchun 4
Dearborn 4
Dong Ket 4
Florianópolis 4
Hefei 4
Messina 4
Monmouth Junction 4
Rio de Janeiro 4
Tokyo 4
Zhengzhou 4
Bangalore 3
Brno 3
Catanzaro 3
Chions 3
Curitiba 3
Den Haag 3
Gravina di Catania 3
Guarulhos 3
João Pessoa 3
Lanzhou 3
London 3
Melbourne 3
Mountain View 3
New York 3
Padova 3
Patti 3
Providence 3
Salerno 3
Totale 6.403
Nome #
microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches 446
Small Extracellular Vesicles Secreted by Nigrostriatal Astrocytes Rescue Cell Death and Preserve Mitochondrial Function in Parkinson's Disease 107
Extracellular vesicles as nanotherapeutics for Parkinson’s disease 94
Vulnerability to Parkinson's Disease: Towards an Unifying Theory of Disease Etiology 89
Regulating Wnt signalling, a strategy to prevent neurodegeneration and induce regeneration 84
Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain 82
A physiological role for the neuropeptide luteinizing hormone-releasing hormone (LHRH) during the maturation of thymus Gland function 79
High-resolution respirometry reveals mpp+ mitochondrial toxicity mechanism in a cellular model of parkinson’s disease 78
Activation of cytosolic phospholipase A2 and 15-lipoxygenase by oxidized low-density lipoproteins in cultured human lung fibroblasts 77
Glia-Derived Extracellular Vesicles in Parkinson's Disease 77
Extracellular vesicles as novel diagnostic and prognostic biomarkers for Parkinson’s disease 77
A Wnt1 regulated Frizzled-1/beta-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection 76
Ultrastructural and molecular characterization of astrocyte-derived extracellular vesicles from nigrostriatal brain regions: implications for dopaminergic neuroprotection 75
Aging of the reproductive-neuroimmune axis. A crucial role for the hypothalamic neuropeptide luteinizing hormone-releasing hormone 73
46. Ruolo dei fattori di crescita di origine astrogliale ed esogeni nella migrazione, crescita, differenziazione e controllo funzionale di neuroni ipotalamici immortalizzati LH-RH secernenti. 71
MAPKs mediate activation of cytosolic phospholipase A2 by amyloid β(25-35) peptide in bovine retina pericytes 71
Opposite changes of pituitary and ovarian receptors for LHRH in ageing rats: further evidence for a direct neural control of ovarian LHRH receptor activity 68
Aging-induced Nrf2-ARE pathway disruption in the subventricular zone drives neurogenic impairment in parkinsonian mice via PI3/Akt/Wnt/β-catenin signaling dysregulation 68
Involvement of CD45 in dexamethasone- and heat shock-induced apoptosis of rat thymocytes. 66
Chemokine-driven molecular cascade orchestrates injury and repair in the MPTP mouse model of basal ganglia injury: The chief instructive role of Writ and concerted glia-neuron cross-talk 66
Activation of phospholipase A2 and MAP kinases by oxidized low density lipoproteins in immortalized GP8.39 endothelial cells 66
Luteinizing hormone-releasing hormone is a primary signaling molecule in the neuroimmune network 66
Neuroendocrineimmunology (NEI) at the turn of the century: towards a molecular understanding of basic mechanisms and implications for reproductive physiopathology 65
The MPTP mouse model: Cues on DA release and neural stem cell restorative role 65
BASIC FIBROBLAST GROWTH FACTOR (bFGF) PRIMING INCREASES THE RESPONSIVENESS OF IMMORTALIZED HYPOTHALAMIC LHRH NEURONS TO NEUROTROPHIC FACTORS 65
Mastering the Tools: Natural versus Artificial Vesicles in Nanomedicine 65
Inflammatory biomarkers in blood of patients with acute brain ischemia 64
Lutheinizing hormone-realeasing hormone (LH-RH) agonist restoration of age associated decline of thymus weight, thymic LH-RH receptors, and thymocyte proliferative capacity 64
Peptidergic modulation of immune system development: role of luteinizing hormone-releasing hormone. 64
Upregulation of lymphocyte beta-adrenergic receptor in Down's syndrome: a biological marker of a neuroimmune deficit 63
Acute brain ischemia and inflammation: an outcome study 63
Luteinizing hormone- releasing hormone-binding sites in the rat thymus : characteristics and biological function 63
Apoptotic cell death and amyloid precursor protein signaling in neuroblastoma SH-SY5Y cells. 63
Proteomic profile of extracellular vesicles secreted by astrocytes using high resolution mass spectrometry 62
Cross-talk signals in the CNS: role of neurotrophic and hormonal factors, adhesion molecules and intercellular signaling agents in luteinizing hormone-releasing hormone (LHRH)-astroglial interactive network. 62
Phosphatidylserine counteracts physiological and pharmacological suppression of humoral immune response. 62
Basic fibroblast growth factor (bFGF) acts on both neurons and glia to mediate the neurotrophic effects of astrocytes on LHRH neurons in culture 62
Cross-talk communication in the neuroendocrine-reproductive-immune axis. Age-dependent alterations in the common communication networks. 62
Partial blockade of T-cell differentiation during ontogeny and marked alterations of the thymic microenvironment in transgenic mice with impaired glucocorticoid receptor function 62
GLUCOCORTICOID-CYTOKINE INTERACTIONS - TYPE-II GLUCOCORTICOID RECEPTOR GENE-EXPRESSION IN THE THYMUS IS DOWN-REGULATED BY IMMUNE-SYSTEM ACTIVATION 62
Glia as a Turning Point in the Therapeutic Strategy of Parkinson's Disease 60
Specificity of the direct effect of an LHRH agonist on testicular 17-hydroxylase but not on 5 alpha-reductase activity in hypophysectomized adult rats. 60
Thymocytes express a mRNA that is identical to hypothalamic luteinizing hormone-releasing hormone mRNA. 60
Luteinizing hormone-releasing hormone signaling at the lymphocyte involves stimulation of interleukin-2 receptor expression. 60
Beta-adrenergic receptors in the rat mammary gland during pregnancy and lactation: characterization, distribution, and coupling to adenylate cyclase. 59
Chitotriosidase in patients with acute ischemic stroke 58
Modulation of hippocampal LHRH receptors by sex steroids in the rat. 58
Modulation of glucocorticoid receptor gene expression in the thymus by the sex steroid hormone milieu and correlation with sexual dimorphism of immune response 58
The immune response evokes up- and down-modulation of beta 2-adrenergic receptor messenger RNA concentration in the male rat thymus. 58
ADRENAL-STEROIDS STIMULATE GROWTH AND PROGESTERONE-RECEPTOR LEVELS IN RAT UTERUS AND DMBA-INDUCED MAMMARY-TUMORS 58
BETA-ADRENERGIC RECEPTORS IN DIMETHYLBENZ(A)ANTHRACENE (DMBA)-INDUCED MAMMARY-TUMORS IN THE RAT AND THEIR MODULATION BY ESTROGENS 58
Adrenal steroids stimulate growth and progesterone receptor levels in rat uterus and DMBA-induced mammary tumors. 57
The thymus gland as a major target for the central nervous system and the neuroendocrine system: Neuroendocrine modulation of thymic beta(2)-Adrenergic receptor distribution as revealed by in vitro autoradiography. 57
Brain dysfunction and the immune system: lymphocyte's beta-adrenergic receptor in Down syndrome. 57
Insulin-like growth factor-I effects on ADP-Ribosylation processes and interactions with glucocorticoids during maturation and differentiation of astroglial cells in primary culture. 57
Neural mechanisms in gonadal and adrenal hyperhophy. 57
Beta-adrenergic receptors in DMBA-induced rat mammary tumors: correlation with progesterone receptor and tumor growth. 57
Brain endothelial cell-retinal pericyte co-cultures induce cytosolic phospholipase A2 protein expression through activation of PKCa and d isoforms and MAPK/ERK cascade 57
Effect of 17-beta estradiol and epidermal growth factor on DNA and RNA labeling in astroglial cells during development, maturation and differentiation in culture 57
Basic fibroblast growth factor priming increases the responsiveness of immortalized hypothalamic luteinizing hormone releasing hormone neurones to neurotrophic factors 57
Astrocytes from distinct nigrostriatal brain regions secrete extracellular vesicles able to mediate neuroprotection in cellular models of Parkinson's disease 56
Therapeutic perspectives in psychoneuroendocriimmunology (PNEI): potential role of phosphatidylserine in neuroendocrine-immune communications 56
Neuroinfiammazione, NOS inducibile e glucocorticoidi nella programmazione della vulnerabilità al danno neurodegenerativo 56
Unilateral ovariectomy-induced luteinizing hormone-releasing hormone content changes in the two halves of the mediobasal hypothalamus. 56
Blockade of central and peripheral luteinizing hormone-releasing hormone (LHRH) receptors in neonatal rats with a potent LHRH-antagonist inhibits the morphofunctional development of the thymus and maturation of the cell-mediated and humoral immune responses. 56
Norepinephrinergic involvement in the neuronal mechanism regulating compensatory ovarian hypertrophy. 56
Wnt your brain be inflamed? Yes, it Wnt! 55
Neuroinflammation and oxidative stress up-regulate and translocate multi-drug resistance-associated protein1 (Mrp1) in mouse astroglia 55
Effect of EGF, IGF-I and insulin on protein labeling in bFGF pretreated or unpretreated nerve cell cultures during LHRH neuron-astrocyte interactions. 55
Immortalized hypothalamic luteinizing hormone-releasing hormone (LHRH) neurons induce a functional switch in the growth factor responsiveness of astroglia: involvement of basic fibroblast growth factor 55
Reactive astrocytes are key players in nigrostriatal dopaminergic neurorepair in the MPTP mouse model of Parkinson's disease: focus on endogenous neurorestoration. 54
Steroid hormone modulation of glial inducible nitric oxide synthase orchestrate neuroprotection in experimental parkinsonisin 54
Multiple sclerosis and anti-Plasmodium falciparum innate immune response 54
Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway 54
Ovarian adrenergic nerves directly participate in the control of luteinizing hormone-releasing hormone and beta-adrenergic receptors during puberty: a biochemical and autoradiographic study. 54
Exposure to a dysfunctional GR from early embryonic life programs the resistance to experimental autoimmune encephalomyelitis via NO-induced immunosuppression. J. Immunology 53
Changes in hippocampal LH-RH receptor density during maturation and aging in the rat. 53
BLOCKADE OF CENTRAL AND PERIPHERAL LUTHEINIZING HORMONE- RELEASING HORMONE (LH-RH) RECEPTORS IN NEONATOL RATS WITH A PATENT LH-RH ANTAGONIST INHIBITS THE MORFOFUNCTIONAL DEVELOPMENT OF THE THYMUS AND MATURATION OF THE CELL-MEDIATED AND HUMORAL IMMUNE RESPONSES 53
Tossicità epatica 53
Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental Parkinsonism: pivotal role for glia-neuron interactions 53
Further characterization of the direct inhibitory effect of LHRH agonists at the testicular level in the rat. 52
Glucorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide 52
Effetti di fattori di crescita endogeni rilasciati dai medium condizionati astrogliali sulla sintesi del DNA in colture di astrociti pretrattate con fattori di crescita esogeni 52
Gender, neuroendocrine-immune interactions and neuron-glial plasticity. Role of luteinizing hormone-releasing hormone (LHRH). 52
Impact of gender on longevity?: Estrogens modulation of neuroendocrine-immune axis and their possible role in aging pathologies 51
Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone 51
Prevention of compensatory ovarian hypertrophy by local treatment of the ovary with 6-OHDA. 51
Dissociated changes of pituitary luteinizing hormone-releasing hormone (LHRH) receptors and responsiveness to the neurohormone induced by 17 beta-estradiol and LHRH in vivo in the rat. 51
I fattori di crescita EGF, IGF-I ed insulina stimolano la sintesi del DNA nelle colture astrogliali e neuronali pretrattate con bFGF. 50
The reproductive system at the neuroendocrine-immune interface: focus on LHRH, estrogens and growth factors in LHRH neuron-glial interactions 50
Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain via an Nrf2-Driven Wnt/β-Catenin Prosurvival Axis 50
Modulation of pituitary luteinizing hormone releasing hormone receptors by sex steroids and luteinizing hormone releasing hormone in the rat. 49
Therapeutic perspectives in psychoneuroendocrinimmunology (PNEI): potential role of phosphatidylserine in neuroendocrine-immune communications. 49
A potential role for catecholamines in the development and progression of carcinogen-induced mammary tumors: hormonal control of beta-adrenergic receptors and correlation with tumor growth. 49
Monoaminergic regulation of LHRH in the organon vasculosum of lamina terminalis (OVLT) 49
Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration 49
Glia-neuron crosstalk in neuroinflammation, neurodegeneration and neuroprotection 48
Characterization, expression, and hormonal control of a thymic beta 2-adrenergic receptor. 48
The LHRH-astroglial network of signals as a model to study neuroimmune interactions: assessment of messenger systems and transduction mechanisms at cellular and molecular levels. 48
Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1) 48
Totale 6.444
Categoria #
all - tutte 35.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.826


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020141 0 0 0 0 0 0 0 0 0 0 90 51
2020/20211.078 4 85 158 9 271 23 148 6 97 8 227 42
2021/20221.297 163 175 1 31 201 31 192 48 120 2 36 297
2022/20231.902 179 46 28 135 202 358 14 334 514 14 43 35
2023/2024659 63 75 30 46 25 79 23 67 4 15 129 103
2024/20252.594 42 397 180 101 797 274 84 155 232 298 34 0
Totale 9.226